ZÁBRADY, Matej, Vendula HRDINOVÁ, Bruno MÜLLER, Udo CONRAD, Jan HEJÁTKO and Lubomír JANDA. Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies. PLOS ONE : Public Library of Science. San Francisco: Public Library Science, 2014, vol. 9, No 10, p. "nestránkováno", 9 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0109875.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Targeted In Vivo Inhibition of Specific Protein–Protein Interactions Using Recombinant Antibodies
Authors ZÁBRADY, Matej (703 Slovakia, belonging to the institution), Vendula HRDINOVÁ (203 Czech Republic, belonging to the institution), Bruno MÜLLER (756 Switzerland), Udo CONRAD (276 Germany), Jan HEJÁTKO (203 Czech Republic, belonging to the institution) and Lubomír JANDA (203 Czech Republic, guarantor, belonging to the institution).
Edition PLOS ONE : Public Library of Science, San Francisco, Public Library Science, 2014, 1932-6203.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.234
RIV identification code RIV/00216224:14740/14:00074131
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1371/journal.pone.0109875
UT WoS 000343941200081
Keywords in English recombinant antibodies;immunomodulation;inhibition;protein-protein interactions;cytokinin signaling pathway
Tags kontrola MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 10/3/2015 19:08.
Abstract
With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated “silencing” represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein–protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
EE2.3.20.0189, research and development projectName: Rozvoj výzkumné excelence v oblasti evoluční cytogenomiky, epigenetiky a buněčné signalizace
GAP305/11/0756, research and development projectName: Strukturní princip specificity přenosu signálu v rostlinách: síť interakcí příjímačové domény histidinkinas u Arabidospis (Acronym: HKRD-AHP)
Investor: Czech Science Foundation
GA13-25280S, research and development projectName: Elucidating molecular mechanisms of cytokinins-ethylene crosstalk in the plant development
Investor: Czech Science Foundation
GA521/09/1699, research and development projectName: Imunomodulace jako nástroj funkční proteomiky při studiu cytokininové signální dráhy u Arabidopsis thaliana
Investor: Czech Science Foundation, Immunomodulation as a functional proteomics tool for cytokinin signaling study in Arabidopsis thaliana
261863, interní kód MUName: BioNMR Facilities - Bio NMR (Acronym: BioNMR)
Investor: European Union, Capacities
PrintDisplayed: 16/8/2024 22:32